Urine Concentrations of Repetitive Doses of Inhaled Salbutamol

Abstract

We examined blood and urine concentrations of repetitive doses of inhaled salbutamol in relation to the existing cut-off value used in routine doping control. We compared the concentrations in asthmatics with regular use of beta2-agonists prior to study and healthy controls with no previous use of beta2-agonists. We enrolled 10 asthmatics and 10 controls in an open-label study in which subjects inhaled repetitive doses of 400 microgram salbutamol every second hour (total 1 600 microgram), which is the permitted daily dose by the World Anti-Doping Agency (WADA). Blood samples were collected at baseline, 30 min, 1, 2, 3, 4, and 6 h after the first inhalations. Urine samples were collected at baseline, 0–4 h, 4–8 h, and 8–12 h after the first inhalations. Median urine concentrations peaked in the period 4–8 h after the first inhalations in the asthmatics and between 8–12 h in controls and the median ranged from 268 to 611 ng×mL⁻¹. No samples exceeded the WADA threshold value of 1 000 ng×mL⁻¹ when corrected for the urine specific gravity. When not corrected one sample exceeded the cut-off value with urine concentration of 1 082 ng×mL⁻¹. In conclusion we found no differences in blood and urine concentrations between asthmatic and healthy subjects. We found high variability in urine concentrations between subjects in both groups. The variability between subjects was still present after the samples were corrected for urine specific gravity.

Key words

beta2-agonists - pharmacokinetics - doping - asthma

References

• 1 Anderson PJ. Pharmacokinetics of (R,S)-albuterol after aerosol inhalation in healthy adult volunteers.  J Pharm Sci. 1998;  87 841-844
• 2 Anderson SD, Argyros GJ, Magnussen H, Holzer K. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction.  Br J Sports Med. 2001;  35 344-347
• 3 ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;  171 912-930
• 4 Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary.  Eur Respir J. 2008;  31 143-178
• 5 Berges R, Segura J, Ventura R, Fitch KD, Morton AR, Farré M, Mas M, de La Torre X. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.  Clin Chem. 2000;  46 1365-1375
• 6 Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Bouglas G, Muers M, Smith D, White J. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systemic review of the literature.  Health Technol Assess. 2001;  5 1-149
• 7 Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, Cummiskey J, Delgado L, Del Giacco SR, Drobnic F, Haahtela T, Larsson K, Palange P, Popov T, van Cauwenberge P. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN.  Allergy. 2008;  63 387-403
• 8 Dreborg S. The skin prick test: methodological studies and clinical applications. Linköping University, Linköping, Sweden; 1987
• 9 Elers J, Pedersen L, Henninge J, Lund TK, Hemmersbach P, Dalhoff K, Backer V. Blood and urinary concentrations of salbutamol in asthmatic subjects.  Med Sci Sports Exerc. 2010;  42 244-249
• 10 Elers J, Strandbygaard U, Pedersen L, Backer V. Daily use of salmeterol causes tolerance to bronchodilation with terbutaline in asthmatic subjects.  Open Respir Med J. 2010;  21; 4 48-50
• 11 Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. Beta2-agonist tolerance and exercise-induced bronchospasm.  Am J Respir Crit Care Med. 2002;  165 1068-1070
• 12 Harriss DJ, Atkinson G. International Journal of Sports Medicine – Ethical Standards in Sport and Exercise Science Research.  Int J Sports Med. 2009;  30 701-702
• 13 Helenius IJ, Tikkanen HO, Haahtela T. Association between type of training and risk of asthma in elite athletes.  Thorax. 1997;  52 157-160
• 14 Helenius IJ, Tikkanen HO, Sarna S, Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors.  J Allergy Clin Immunol. 1998;  101 646-652
• 15 Nysom K, Ulrik CS, Hesse B, Dirksen A. Published models and local data can bridge the gap between reference values of lung function for children and adults.  Eur Respir J. 1997;  10 1591-1598
• 16 Pichon A, Venisse N, Krupka E, Pérault-Pochat MC, Denjean A. Urinary and blood concentrations of beta-2-agonists in trained subject: comparison between routes of use.  Int J Sports Med. 2006;  27 187-192
• 17 Schweizer C, Saugy M, Kamber M. Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete.  Clin J Sport Med. 2004;  14 312-315
• 18 Sporer BC. Dose response of inhaled salbutamol on exercise performance and urine concentrations.  Med Sci Sports Exerc. 2008;  40 149-157
• 19 Sporer BC. Inhaled salbutamol and doping control: effects of dose on urine concentrations.  Clin J Sport Med. 2008;  18 282-285
• 20 The Global Strategy for Asthma Management and Prevention. . Global Initiative for Asthma (GINA).  2008;  available on http://www.ginasthma.com
• 21 Thomsen SF, Ulrik CS, Larsen K, Backer V. Change in prevalence of asthma in Danish children and adolescents.  Ann Allergy Asthma Immunol. 2004;  92 506-511
• 22 Ventura R, Segura J, Berges R, Fitch KD, Morton AR, Berruezo S, Jiménez C. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control.  Ther Drug Monit. 2000;  22 277-282
• 23 Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness.  Thorax. 1983;  38 760-765

Correspondence